Alpha-adrenergic inhibition of immunoreactive insulin release during deep hypothermia.
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature; D003981:Diazoxide / Q000494:pharmacology; D004195:Disease Models, Animal; D004285:Dogs; D005934:Glucagon / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects; D006830:Hydralazine / Q000494:pharmacology; D007035:Hypothermia / Q000378:metabolism*; D007118:Immunoassay; D007328:Insulin / Q000097:blood* / Q000378:metabolism; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000502:physiology*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D001786:Blood Glucose; D007328:Insulin; D006830:Hydralazine; D005934:Glucagon; D011433:Propranolol; D005947:Glucose; D003981:Diazoxide; D010646:Phentolamine